LONGER-TERM USE OF THE THROMBOPOIETIN-MIMETIC PEPTIBODY ROMIPLOSTIM IN CHILDREN WITH CHRONIC/REFRACTORY IMMUNE THROMBOCYTOPENIA (ITP): RESULTS OF AN OPEN-LABEL EXTENSION STUDY

被引：0

作者：

Nugent, Diane ^{[1
]}

Bussel, James ^{[1
]}

Buchanan, George ^{[1
]}

Stine, Kimo ^{[1
]}

Kalpatthi, Ramasubramanian ^{[1
]}

Nie, Kun ^{[1
]}

Eisen, Melissa ^{[1
]}

机构：

[1] Amgen Inc, Thousand Oaks, CA 91320 USA

来源：

PEDIATRIC BLOOD & CANCER | 2011年 / 56卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：916 / 916

页数：1

共 50 条

[1] Long-Term Use of the Thrombopoietin-Mimetic Romiplostim in Children With Severe Chronic Immune Thrombocytopenia (ITP)
Bussel, James B.
Hsieh, Loan
Buchanan, George R.
Stine, Kimo
Kalpatthi, Ram
Gnarra, David J.
Ho, Richard H.
Nie, Kun
Eisen, Melissa
[J]. PEDIATRIC BLOOD & CANCER, 2015, 62 (02) : 208 - 213
[2] LONG-TERM USE OF THE THROMBOPOETIN RECEPTOR AGONIST ROMIPLOSTIM IN CHILDREN WITH CHRONIC/REFRACTORY IMMUNE THROMBOCYTOPENIA (ITP) IN AN OPEN-LABEL EXTENSION STUDY (OLE)
Bussel, James
Buchanan, George
Gnarra, David
Ho, Richard
Nie, Kun
Eisen, Melissa
[J]. PEDIATRIC BLOOD & CANCER, 2013, 60 : S34 - S34
[3] SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF ROMIPLOSTIM, A THROMBOPOIETIN (TPO)-RECEPTOR-AGONIST, IN THROMBOCYTOPENIC PEDIATRIC PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP) IN AN EXTENSION STUDY
Tarantino, Michael
Bussel, James
Geddis, Amy
Guerrera, Michael
Ikeda, Alan
Nie, Kun
Eisen, Melissa
[J]. PEDIATRIC BLOOD & CANCER, 2014, 61 : S46 - S46
[4] Long-Term Efficacy and Safety of Romiplostim Treatment of Adult Patients with Chronic Immune Thrombocytopenia (ITP): Final Report from an Open-Label Extension Study
Kuter, David J.
Bussel, James B.
Newland, Adrian
Wasser, Jeffrey S.
Lyons, Roger M.
George, James N.
Macik, Gail
Nie, Kun
Jun, Susie
[J]. BLOOD, 2010, 116 (21) : 36 - 37
[5] SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
Tarantino, M.
Bussel, J.
Blanchette, V.
Despotovic, J.
Bennett, C.
Raj, A.
Williams, B.
Beam, D.
Morales, J.
Rose, M.
Wang, X.
Eisen, M.
[J]. HAEMATOLOGICA, 2016, 101 : 587 - 587
[6] Use of Rituximab in a Study Comparing the Thrombopoietin Mimetic Romiplostim with Standard of Care (SOC) in Patients with Immune Thrombocytopenia (ITP)
Wasser, Jeffrey
Boccia, Ralph Vincent V.
Lyons, Roger M.
Mandanas, Romeo
Pabinger, Ingrid
Michel, Marc
Viallard, Jean-Francois
Wang, Xuena
Lizambri, Richard
[J]. BLOOD, 2011, 118 (21) : 1411 - 1412
[7] Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)
Bussel, James B.
Tarantino, Michael D.
Blanchette, Victor S.
Raj, Ashok
Despotovic, Jenny
Beam, Donald
Roy, John
Wang, Xuena
Mehta, Bhakti
Eisen, Melissa
[J]. BLOOD, 2016, 128 (22)
[8] SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
Bussel, J.
Tarantino, M.
Blanchette, V.
Raj, A.
Despotovic, J.
Beam, D.
Roy, J.
Wang, X.
Mehta, B.
Eisen, M.
[J]. HAEMATOLOGICA, 2017, 102 : 294 - 294
[9] Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)
Bussel, James
Tarantino, Michael
Blanchette, Victor
Raj, Ashok
Despotovic, Jenny
Beam, Donald
Roy, John
Wang, Xuena
Mehta, Bhakti
Eisen, Melissa
[J]. PEDIATRIC BLOOD & CANCER, 2017, 64 : S9 - S9
[10] A Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous Romiplostim in Children with Immune Thrombocytopenia (ITP)
Grainger, John
Bussel, James
Cooper, Nichola
Tarantino, Michael
Blanchette, Victor
Despotovic, Jenny
Maschan, Alexey
Carpenter, Nancy
Eisen, Melissa
Mehta, Bhakti
[J]. PEDIATRIC BLOOD & CANCER, 2017, 64 : S10 - S10

← 1 2 3 4 5 →